149 computer-security "https:" "https:" "https:" "UCL" "UCL" "UCL" positions at ETH Zurich
Sort by
Refine Your Search
-
to commercial-grade systems, we are seeking a visionary Lead Architect to drive the design and development of the V2.0 system. This role is critical for establishing technical novelty, securing a new IP portfolio
-
for key program deliverables. Drive the development of high-impact deliverables, such as the annual report and the Phase III Outline Proposal. Coordinate input across projects, synthesize insights, and
-
natural plant defenses and reduce pathogen entry into leafy vegetables, contributing to sustainable agriculture and improved food safety.
-
100%, Zurich, fixed-term The Clinical Genomics team led by Dr. André Kahles at the Biomedical Informatics Lab (BMI Lab), headed by Prof. Gunnar Rätsch, at ETH Zurich, is seeking a highly motivated
-
of Bern). The position will be hosted at the Institute for Atmospheric and Climate Science at ETH Zurich and will be part of the NCCR CLIM+ programme which is funded by the Swiss National Science
-
organised individual to support multiple experimental and computational research groups. The successful candidate will contribute to both a collaborative research network and institute-wide activities
-
-phonon coupling elements. With these, dedicated scattering rates can be computed and then used in quantum transport simulations. Down the line, we aim to pre-train a common GNN backbone model capable
-
100%, Basel, fixed-term The Computational Biology (CoBi) group, led by Prof. Dagmar Iber, develops data-driven, mechanistic models of biological systems using advanced imaging and computational
-
work closely with Professor Platt, guide the group’s computational research, contribute to ongoing projects, and pursue independent research directions aligned with the laboratory’s goals. Project
-
100%, Basel, fixed-term The highly competitive Bio-Engineering Systems for Therapeutics (BEST) postdoc program, part of the Next-gen Bioengineers initiative, is run jointly by ETH Zurich and Roche